Combination therapies for COVID-19: An overview of the clinical trials landscape.

Authors:
Akinbolade S; Coughlan D; Fairbairn R; McConkey G; Powell H and 2 more

Journal:
Br J Clin Pharmacol

Publication Year: 2021

DOI:
10.1111/bcp.15089

PMCID:
PMC8652622

PMID:
34558094

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Br J Clin Pharmacol

Abbreviation: Br J Clin Pharmacol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Phase 1 safety, tolerability, pharmacokinetics and pharmacodynamic results of KCL-286, a novel reti…
Goncalves MB; Mant T; Täubel J and 8 more (2023) - Transparency Score: 4/6
A comprehensive pharmacogenomic study indicates roles for SLCO1B1, ABCG2 and SLCO2B1 in rosuvastati…
Lehtisalo M; Taskinen S; Tarkiainen EK and 8 more (2022) - Transparency Score: 3/6
A crossover study evaluating the sex-dependent and sensitizing effects of sleep deprivation using a…
Hijma H; Koopmans I; Klaassen E and 3 more (2022) - Transparency Score: 4/6
Acute response to cholinergic challenge predicts long-term response to galantamine treatment in pat…
Baakman AC; Gavan C; van Doeselaar L and 12 more (2022) - Transparency Score: 4/6
An e-Delphi study to obtain expert consensus on the level of risk associated with preventable e-pre…
Heed J; Klein S; Slee A and 3 more (2022) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"COMPETING INTERESTS There are no competing interests to declare."

Evidence found in paper:

"This project is funded by the NIHR (HSRIC‐2016‐10 009)/Innovation Observatory. The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025